Thickness of the cerebral cortex shows positive association with blood levels of triacylglycerols carrying 18-carbon fatty acids.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
20 08 2020
Historique:
received: 15 03 2020
accepted: 30 07 2020
entrez: 22 8 2020
pubmed: 21 8 2020
medline: 23 6 2021
Statut: epublish

Résumé

Perturbations in fatty acid (FA) metabolism as well as thinning of the cerebral cortex have been associated with cognitive decline in the elderly. Predominant FAs in the brain are docosahexaenoic acid (DHA) and arachidonic acid (ARA). Approximately 2-8% of esterified DHA and 3-5% of esterified ARA in the brain are replaced daily. DHA and ARA are derivatives of 18-carbon essential FAs, α-linolenic acid and linoleic acid, that must be imported into the brain from the circulation. In blood, FAs are primarily transported in triacylglycerols (TAGs) from which they can be released at the blood-brain-barrier and transported inside the brain. We show that circulating levels of TAGs carrying 18-carbon FAs are positively associated with cortical thickness in middle-aged adults. These associations are stronger in cortical regions with higher expression of genes regulating long-chain FA metabolism and cellular membranes, and cortical thickness in the same regions may be related to cognitive performance.

Identifiants

pubmed: 32820227
doi: 10.1038/s42003-020-01189-5
pii: 10.1038/s42003-020-01189-5
pmc: PMC7441395
doi:

Substances chimiques

Biomarkers 0
Fatty Acids 0
Triglycerides 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

456

Subventions

Organisme : NIA NIH HHS
ID : R01 AG056726
Pays : United States
Organisme : CIHR
Pays : Canada

Références

Bentsen, H. Dietary polyunsaturated fatty acids, brain function and mental health. Microb. Ecol. Health Dis. 28, 1281916 (2017).
pmcid: 5445635
Rapoport, S. I., Chang, M. C. J. & Spector, A. A. Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J. Lipid Res. 42, 678–685 (2001).
pubmed: 11352974 doi: 10.1016/S0022-2275(20)31629-1
Bazinet, R. P. & Layé, S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat. Rev. Neurosci. 15, 771–785 (2014).
pubmed: 25387473 doi: 10.1038/nrn3820
Kris-Etherton, P. M., Hecker, K. D. & Binkoski, A. E. Polyunsaturated fatty acids and cardiovascular health. Nutr. Rev. 62, 414–426 (2004).
pubmed: 15622714 doi: 10.1111/j.1753-4887.2004.tb00013.x
Tortosa-Caparrós, E., Navas-Carrillo, D., Marín, F. & Orenes-Piñero, E. Anti-inflammatory effects of omega 3 and omega 6 polyunsaturated fatty acids in cardiovascular disease and metabolic syndrome. Crit. Rev. Food Sci. Nutr. 57, 3421–3429 (2017).
pubmed: 26745681 doi: 10.1080/10408398.2015.1126549
Cardoso, C., Afonso, C. & Bandarra, N. M. Dietary DHA and health: cognitive function ageing. Nutr. Res. Rev. 29, 281–294 (2016).
pubmed: 27866493 doi: 10.1017/S0954422416000184
Schaefer, E. J. et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and alzheimer disease: the framingham heart study. Arch. Neurol. 63, 1545–1550 (2006).
pubmed: 17101822 doi: 10.1001/archneur.63.11.1545
Zhang, Y. et al. Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies. Am. J. Clin. Nutr. 103, 330–340 (2016).
pubmed: 26718417 doi: 10.3945/ajcn.115.124081
Tracey, T. J., Steyn, F. J., Wolvetang, E. J. & Ngo, S. T. Neuronal lipid metabolism: multiple pathways driving functional outcomes in health and disease. Front. Mol. Neurosci. 11, 1–25 (2018).
doi: 10.3389/fnmol.2018.00010
Pausova, Z. et al. Cohort profile: The Saguenay Youth Study (SYS). Int. J. Epidemiol. 46, e19 (2017).
Sliz, E. et al. A variant near DHCR24 associates with microstructural properties of white matter and peripheral lipid metabolism in adolescents. Mol. Psychiatry https://doi.org/10.1038/s41380-019-0640-9 (2020).
Kettunen, J. et al. Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. Nat. Commun. 7, 11122 (2016).
pubmed: 27005778 pmcid: 4814583 doi: 10.1038/ncomms11122
Millwood, I. Y. et al. Association of CETP gene variants with risk for vascular and nonvascular diseases among Chinese adults. JAMA Cardiol. 3, 34–43 (2018).
pubmed: 29141072 doi: 10.1001/jamacardio.2017.4177
French, L. & Paus, T. A FreeSurfer view of the cortical transcriptome generated from the Allen Human Brain Atlas. Front. Neurosci. 9, 1–5 (2015).
doi: 10.3389/fnins.2015.00323
Shin, J. et al. Cell-specific gene-expression profiles and cortical thickness in the human brain. Cereb. Cortex 28, 3267–3277 (2018).
pubmed: 28968835 doi: 10.1093/cercor/bhx197
Ohkuni, A., Ohno, Y. & Kihara, A. Identification of acyl-CoA synthetases involved in the mammalian sphingosine 1-phosphate metabolic pathway. Biochem. Biophys. Res. Commun. 442, 195–201 (2013).
pubmed: 24269233 doi: 10.1016/j.bbrc.2013.11.036
Mashek, D. G., Li, L. O. & Coleman, R. A. Rat long-chain acyl-CoA synthetase mRNA, protein, and activity vary in tissue distribution and in response to diet. J. Lipid Res. 47, 2004–2010 (2006).
pubmed: 16772660 doi: 10.1194/jlr.M600150-JLR200
Hampshire, A., Highfield, R. R., Parkin, B. L. & Owen, A. M. Fractionating human intelligence. Neuron 76, 1225–1237 (2012).
pubmed: 23259956 doi: 10.1016/j.neuron.2012.06.022
Yuan, P. & Raz, N. Prefrontal cortex and executive functions in healthy adults: a meta-analysis of structural neuroimaging studies. Neurosci. Biobehav. Rev. 42, 180–192 (2014).
pubmed: 24568942 doi: 10.1016/j.neubiorev.2014.02.005
Dickerson, B. C. et al. Detection of cortical thickness correlates of cognitive performance: reliability across MRI scan sessions, scanners, and field strengths. Neuroimage 39, 10–18 (2008).
pubmed: 17942325 doi: 10.1016/j.neuroimage.2007.08.042
Singh, V. et al. Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer’s disease. Brain 129, 2885–2893 (2006).
pubmed: 17008332 doi: 10.1093/brain/awl256
Bernath, M. M. et al. Serum triglycerides in Alzheimer disease. Neurology 94, e2088–e2098 (2020).
Krishnadas, R. et al. Cardio-metabolic risk factors and cortical thickness in a neurologically healthy male population: Results from the psychological, social and biological determinants of ill health (pSoBid) study. NeuroImage Clin. 2, 646–657 (2013).
pubmed: 24179815 pmcid: 3777783 doi: 10.1016/j.nicl.2013.04.012
Schwarz, N. F. et al. Differential associations of metabolic risk factors on cortical thickness in metabolic syndrome. NeuroImage Clin. 17, 98–108 (2018).
pubmed: 29062686 doi: 10.1016/j.nicl.2017.09.022
Vessby, B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr. Opin. Lipidol. 14, 15–19 (2003).
pubmed: 12544656 doi: 10.1097/00041433-200302000-00004
Dyerberg, J., Madsen, P., Møller, J. M., Aardestrup, I. & Schmidt, E. B. Bioavailability of marine n-3 fatty acid formulations. Prostaglandins Leukot. Essent. Fat. Acids 83, 137–141 (2010).
doi: 10.1016/j.plefa.2010.06.007
Pélerin, H. et al. Gene expression of fatty acid transport and binding proteins in the blood-brain barrier and the cerebral cortex of the rat: Differences across development and with different DHA brain status. Prostaglandins Leukot. Essent. Fat. Acids 91, 213–220 (2014).
doi: 10.1016/j.plefa.2014.07.004
Banks, W. A. et al. Triglycerides cross the blood-brain barrier and induce central leptin and insulin receptor resistance. Int. J. Obes. 42, 391–397 (2018).
doi: 10.1038/ijo.2017.231
Clark, K. J., Makrides, M., Neumann, M. A. & Gibson, R. A. Determination of the optimal ratio of linoleic acid to alpha-Iinolenic acid in infant formulas. J. Pediatr. 120, S151–S158 (1992).
pubmed: 1348533 doi: 10.1016/S0022-3476(05)81250-8
Gazzah, N. et al. Decrease of brain phospholipid synthesis in free‐moving n‐3 fatty acid deficient rats. J. Neurochem. 64, 908–918 (1995).
pubmed: 7830085 doi: 10.1046/j.1471-4159.1995.64020908.x
Igarashi, M. et al. Docosahexaenoic acid synthesis from α-linolenic acid by rat brain is unaffected by dietary n-3 PUFA deprivation. J. Lipid Res. 48, 1150–1158 (2007).
pubmed: 17277380 doi: 10.1194/jlr.M600549-JLR200
Naudí, A. et al. Lipidomics of human brain aging and alzheimer’s disease pathology. Int. Rev. Neurobiol. 122, 133–189 (2015).
pubmed: 26358893 doi: 10.1016/bs.irn.2015.05.008
Kim, H. et al. Oleic acid ameliorates Aβ-induced inflammation by downregulation of COX-2 and iNOS via NFκB signaling pathway. J. Funct. Foods 14, 1–11 (2015).
doi: 10.1016/j.jff.2015.01.027
Snowden, S. G. et al. Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: a nontargeted metabolomic study. PLoS Med. 14, 1–19 (2017).
doi: 10.1371/journal.pmed.1002266
Gao, X., Starmer, J. & Martin, E. R. A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet. Epidemiol. 32, 361–369 (2008).
pubmed: 18271029 doi: 10.1002/gepi.20310
Johnson, R. C. et al. Accounting for multiple comparisons in a genome-wide association study (GWAS). BMC Genomics 11, 724 (2010).
pubmed: 21176216 pmcid: 3023815 doi: 10.1186/1471-2164-11-724
Sliz, E. et al. NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects. Hum. Mol. Genet. 27, 2214–2223 (2018).
pubmed: 29648650 pmcid: 5985737 doi: 10.1093/hmg/ddy124
Patel, Y., Shin, J., Gowland, P. A., Pausova, Z. & Paus, T. Maturation of the human cerebral cortex during adolescence: myelin or dendritic arbor? Cereb. Cortex 29, 3351–3362 (2019).
pubmed: 30169567 doi: 10.1093/cercor/bhy204
Szklarczyk, D. et al. STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607–D613 (2019).

Auteurs

Eeva Sliz (E)

The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Departments of Physiology and Nutritional Sciences, University of Toronto, Toronto, ON, Canada.

Jean Shin (J)

The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Departments of Physiology and Nutritional Sciences, University of Toronto, Toronto, ON, Canada.

Catriona Syme (C)

The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Departments of Physiology and Nutritional Sciences, University of Toronto, Toronto, ON, Canada.

Sandra Black (S)

Department of Medicine (Neurology), University of Toronto, Toronto, ON, Canada.
Toronto Dementia Research Alliance, Toronto, ON, Canada.
Sunnybrook Research Institute, Toronto, ON, Canada.
Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Hurvitz Brain Sciences Program, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
LC Campbell Cognitive Neurology Research Unit, Toronto, ON, Canada.

Sudha Seshadri (S)

The Framingham Heart Study, Framingham, MA, USA.
Department of Neurology, Boston University School of Medicine, Boston, MA, USA.

Tomas Paus (T)

Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, Toronto, ON, Canada.
Departments of Psychology and Psychiatry, University of Toronto, Toronto, ON, Canada.

Zdenka Pausova (Z)

The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada. zdenka.pausova@sickkids.ca.
Departments of Physiology and Nutritional Sciences, University of Toronto, Toronto, ON, Canada. zdenka.pausova@sickkids.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH